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Summary. Many compounds produced by fungi have relevant pharmaceutical applications. The purpose of this study was to
collect and isolate endophytic fungi from different regions of Panama and then to test their potential therapeutic activities against
Leishmania donovani, Plasmodium falciparum, and Trypanosoma cruzi as well as their anticancer activities in MCF-7 cells. Of
the 25 fungal isolates obtained, ten of them had good anti-parasitic potential, showing selective activity against L. donovani; four
had significant anti-malarial activity; and three inhibited the growth of T. cruzi. Anticancer activity was demonstrated in four iso-
lates. Of the active isolates, Edenia sp. strain F0755, Xylaria sp. strain F1220, Aspergillus sp. strain F1544, Mycoleptodiscus sp.
strain F0194, Phomopsis sp. strain F1566, Pycnoporus sp. strain F0305, and Diaporthe sp. strain F1647 showed the most prom-
ise based on their selective bioactivity and lack of toxicity in the assays. [Int Microbiol 2011; 14(2):95-102]
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Introduction 
Parasitic infections are major causes of human chronic dis-
eases in most countries of the tropics. The parasites include
protozoa and helminths, infect billions of people, and the
resulting diseases cause debilitating injuries such as blind-
ness and disfigurement, or death in millions of people.
According to World Health Organization (WHO) estimates,
25% of the human population is infected with parasitic
worms. However, attempts to develop vaccines against these
pathogens have been frustrated by the difficulty of cultivat-
ing the parasites in the laboratory, the complexity of their
multicellular organization and—in many species—their mul-
tistage development, in addition to their impressive antigenic
variability [http://www.who.int/vaccine_research/diseases/
soa_parasitic/en/index.html].
Malaria is the most dangerous parasitic disease, as evi-
denced by the high rates of complications and mortality
caused by the most fatal species, Plasmodium falciparum
[15]. Chagas disease, or American trypanosomiasis, is a
potentially life-threatening two-phase illness caused by the
protozoan Trypanosoma cruzi. The acute phase persists for
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about two months after infection; symptoms are absent or mild
and can include fever, headache, enlarged lymph glands, pal-
lor, muscle pain, difficulty in breathing, swelling, and abdom-
inal or chest pain. In the chronic phase, the parasites reside
mainly in the heart and digestive muscle, resulting in cardiac
disorders in up to 30% of patients and digestive, neurological,
or mixed pathologies in up to 10%. Eventually, the infection
can lead to sudden death or heart failure, caused by progressive
destruction of cardiac muscle [10,15]. Leishmaniasis, a world-
wide disease, is caused by several species of the flagellated
protozoan parasite Leishmania. In its more severe forms, the
disease causes serious disfigurement and may be fatal. The
WHO estimates a worldwide prevalence of leishmaniasis of
approximately 12 million cases, with an annual mortality of
about 60,000 and approximately 350 million people at risk.
The expansion of leishmaniasis and the alarming rise in the
number of cases has been attributed to environmental changes,
such as deforestation, dam construction, new irrigation
schemes, and the migration of non-immune individuals to
endemic areas [10,15].
At the same time, the frequency of drug-resistant parasites
has greatly increased and most treatments involve highly toxic
drugs. In addition, the chemotherapeutic agents used in
patients with these diseases have lacked effectiveness. Thus,
there is an urgent need to search for novel drugs from previ-
ously unexplored sources, including natural products, to com-
bat the global health problems posed by parasitic infections.
Cancer is another major cause of mortality worldwide; in
2008, it accounted for 7.6 million deaths. According to WHO
forecasts, an increase to 11 million deaths annually is expected
by 2030. The prevalence is higher in low and middle-income
countries.
As a part of the on-going research activities, the Pana-
manian International Cooperative Biodiversity Group
(ICBG) [17] recently decided to explore endophytic fungi as
a source of molecules with antiparasitic and anticancer bioac-
tivities [18,21,22]. Within the ICBG program, we have
assayed the antiparasitic and in vitro anticancer activities of
25 isolates, while also analyzing the effect of the culture
medium on the production of secondary metabolites by
Panamanian endophytic fungi. The results of these studies
are reported and discussed herein.
Materials and methods
Microorganisms and maintenance. The endophytic fungi used in
this study were isolated from the leaves of nineteen plants collected in
Panama’s protected areas, including Coiba, Barro Colorado Islands, and
Altos de Campana National Park. Harvested leaves were washed in running
tap water and processed as follows: 96 adjacent 1-mm × 2-mm segments
were cut from the lamina, midway between the petiole and leaf tip. The seg-
ments were surface-sterilized by washing them for 2 min in 0.525% sodium
hypochlorite and then for 2 min in 70% ethanol [1]. Subsequently, 24 seg-
ments were arbitrarily selected and placed on Petri dishes containing 2%
malt extract agar (MEA). The plates were incubated on laboratory benches
at room temperature with ambient light. Every 3 days for 21 days, fungal
growth from the leaf segments was monitored. Hyphal tips from distinct
colonies emerging from leaf segments were subcultured on fresh 2% MEA
plates to obtain pure colonies. 
Endophytic fungi identification. The fungi, most of which did not
fruit in culture, were tentatively identified by molecular phylogenetic analy-
ses of the fast-evolving nuclear ribosomal internal transcribed spacer (ITS),
a ca. 600-bp locus frequently used in fungal systematics at the species level
[2]. Total fungal genomic DNA was extracted directly from fresh, axenic
mycelia using an SDS extraction protocol. The DNA was diluted 1:10 and
then used to PCR-amplify the ITS region. The PCR products were purified,
visualized on a 1% agarose gel, and sequenced in two directions on an ABI
3700 automated sequencer using the PCR primers ITS5 and ITS4. The
resulting sequences were assembled into contigs and basecalls edited manu-
ally. The consensus sequences were subjected to BLAST searches of the
NCBI GenBank database [http://blast.ncbi.nlm.nih.gov/Blast.cgi] for pre-
liminary identification. The sequences for each species were deposited at the
Smithsonian Tropical Research Institute. The organisms were maintained on
MEA slants.
Fungal culture conditions. The fungi were grown on a small scale
using four types of liquid culture media: (i) modified malt extract (MME),
consisting of 10 g malt extract (Scharlau Chemie), 0.5 g mycological pep-
tone (Fluka, Sigma-Aldich Chemie), and 10 g dextrose (Mallinckrodt
Baker); (ii) potato dextrose broth (PDB, Sigma-Aldrich Chemie); (iii)
Czapex Dox (CD, Sigma-Aldrich Chemie); and (iv) V8, containing 90 ml
V8 vegetable juice (Campbells) and 1 g calcium carbonate (Sigma-Aldrich
Chemie). Five hundred ml of each of the sterile media were placed in1-liter
Erlenmeyer flasks and inoculated with small pieces of actively growing
mycelium (0.5 cm2). The cultures were incubated at 30°C under orbital agi-
tation (150 rpm) for 15 days.
Production of extracts. After incubation, the contents of the flasks
were membrane-filtered (0.45-mm-pore-size, Millipore) and the filtrate then
extracted exhaustively with ethyl acetate. The organic phase was vacuum-
concentrated to obtain the extracts. Mycelia were lyophilized and extracted
with the same solvent. 
In vitro antiparasitic assays: Leishmania. Axenically grown (cell-
free) amastigotes of L. donovani (LD-1S/MHOM/SD/00-strain 1S), the
species responsible for the visceral and potentially lethal form of the disease,
were used in the bioassay. Parasite growth and survival were measured using
the fluorochrome PicoGreen, an ultrasensitive fluorescent nucleic acid strain
for measuring double-stranded DNA. Samples to be screened were first test-
ed in duplicate at a single concentration of 10 μg/ml [6]. The results were
expressed as percentage of parasite inhibitory growth (% IG) compared to
the control. Samples with an IG value ≥65% were considered active. The
fungal compounds were assayed at six concentrations (0.00032, 0.0016,
0.08, 0.4, 2, and 10 μg/ml) to determine the IC50 values. Amphotericin B was
used as a positive control; the typical IC50 response of L. donovani to this
drug is 70–120 ng/μl.
In vitro antiparasitic assays: Plasmodium. Antiplasmodial activity
was evaluated using a fluorometric method in which parasite DNA is detected
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with the fluorochrome PicoGreen in a chloroquine-resistant strain (Indocrina
W2) of Plasmodium falciparum, as described in [2]. The parasites were
maintained in vitro by a modification of the method of Trager and Jensen.
Chloroquine served as a positive control (IC50 = 80–100 nM) [5]. The results
were expressed as the %IG (as defined above) compared to the chloroquine
control. Samples with IG values ≥65% were considered active.
In vitro antiparasitic assays: Trypanosoma cruzi. Antitrypano-
somal bioassays were performed using a colorimetric method. The inhibition
of parasite growth was assessed based on the expression of the reporter gene
for β-galactosidase (β-Gal) in the recombinant Tulahuen clone C4 of T. cruzi.
The assays were performed in triplicate on amastigotes—the intracellular form
of the parasite infecting African green monkey kidney (Vero) cells—exposed
for 120 h to different concentrations (10, 2, and 0.4 μg/ml) of the test com-
pounds at 37°C under an atmosphere of 5% CO2/95% air [6]. The intensity of
the color, indicating the amount of cleavage of chlorophenol red-β-D-galacto-
side (CPRG) by β-Gal expressed by the parasite, was measured at 570 nm
using a Benchmark Bio-Rad microplate reader. The results were expressed as
the %IG (as defined above) compared to the nifurtimox control. Samples with
IG values ≥65% were considered active [4].
In vitro cytotoxicity assays. The cytotoxic activity of the test com-
pounds against the human breast cancer cell line MCF-7 was determined fol-
lowing the standard protocol of the U.S. National Cancer Institute [23]. Vero
cells adhering to 96-well plates were used to evaluate the toxicity of the
compounds purified from Aspergillus sp. strain F1544 on the basis of the
reduction of 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bro-
mide (MTT, Sigma). The cells were treated with the test compound for 4 h
at 37°C, after which cell viability was evaluated in an ELISA reader at 570
nm [23]. The results were expressed as the %IG compared to the ampho-
tericin B control. Samples with IG values ≥65% were considered active.
Large-scale cultures for chemistry. For each culture (Edenia sp.
strain F0755 and Mycosphaerella sp. nov. strain F2140), ten 1-liter
Erlenmeyer flasks, each containing 0.5 l of liquid medium (CD or PD), were
individually inoculated with a 1-cm2 agar plug taken from a stock culture of
the respective fungus. The flasks were placed on an orbital shaker at 150 rpm
and incubated at 30°C for 15 days.
Isolation of compounds from Edenia sp. strain F0755 and
Mycosphaerella sp. nov. strain F2140. Each crude extract was
subjected to open column chromatography (silica gel 60, 70–230 mesh,
Merck), which yielded several fractions. These were subsequently tested for
activity in antiparasitic and anticancer bioassays. Active fractions that gave
rise to large peaks were further fractionated using normal-phase HPLC in the
case of Edenia sp. strain F0755 and reversed-phase HPLC in the case of
Mycosphaerella sp. nov. strain F2140, to yield compounds 1–7. HPLC was
carried out on a Waters LC system, including a 600 pump, a 996 photodiode
array detector, and a YMC-Pack SIL (150–10 mm) NP-HPLC column. All
solvents were HPLC grade and were used without further purification.
Structural elucidation. Nuclear magnetic resonance (NMR) spectra
were recorded on a Bruker Avance 300-MHz spectrometer at 300 MHz (1H)
or 75 MHz (13C) using TMS as an internal chemical shift reference. The
spectra were recorded in CDCl3, with the solvent signals at d 7.26 (for pro-
tons) and d 77.0 (for carbon) used as references. Mass spectra were obtained
in a mass spectrometer APCI-HR-MS (JEOL LC-mate mass spectrometer).
Results and Discussion
Twenty five strains of endophytic fungi were isolated from
the leaves of plants collected in Panama’s protected areas
with the aim of screening the isolates for antiparasitic and
anticancer bioactivities (Table 1). 
Some of these isolates were tentatively identified on the
basis of careful evaluation of sequence similarity to known
species available through GenBank. Others could not be
identified due to a lack of sporulation and because there were
no closely related species available in online databases for
phylogenetic analysis. Alignments of the ITS regions of 12
isolates showed 100% identity with sequences deposited in
GenBank, while for 13 other isolates this same high identity
was lacking. Based on the molecular identification, four of
the isolates obtained were Xylaria sp., three were Diaporthe
sp., two were Cercophora sp., two were Edenia sp., and the
remaining 14 belonged to different families. These results
reflect the great diversity of fungal endophytes associated
with various Panamanian plants. They also suggest that the
composition and distribution of fungal endophytes are
notably affected by the specific environment and by the
fungi’s hosts. 
Most of the fungal families identified in this study have
been previously reported as endophytes in other plants.
Colletotrichum species are involved in plant diseases; in fact,
this genus is listed among the most destructive post-harvest
pathogens of cereals, legumes, fruits, and vegetables [11].
Diaporthe species, which are commonly found as endo-
phytes, are also considered as pathogens, causing important
economic losses in some countries [29]. Xylaria is often
found in dead wood; note that one species of this family, iso-
lated from Siparuna sp. (Siparunaceae), reportedly shows
antimalarial activity [18]. 
Following isolation of the endophytes, fermentation was
carried out on small scale. The resulting culture broths were
separated from the mycelia by filtration under vacuum and
the filtrate submitted to liquid-liquid partition with ethyl
acetate (EtOAc). The organic solvent was evaporated under
reduced pressure to dryness to yield an EtOAc extract.
Mycelia were extracted with the same solvent. Because of
their chromatographic similarities, as determined by thin-
layer chromatography, the extracts were pooled to yield a sin-
gle fungal extract for each of the different culture media. The
activities of these extracts were evaluated against three path-
ogenic parasites, L. donovani, P. falciparum, and T. cruzi, and
against the MCF-7 cancer cell line. The antiparasitic and
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Table 1. Sample ID, isolate code, and results of BLAST searches of NCBI-GenBank using bidirectionally sequenced, manually edited sequence data from
the nuclear ribosomal internal transcribed spacer and 5.8S gene, including accession number, description, and, for those fungi whose top BLAST hits were
to unnamed isolates, the highest-matching named isolate (top named hit). Taxonomy was estimated only on the basis of BLAST analyses, such that these
species and genus names should be treated as estimations, rather than as the definitive identities of these fungi
Sample Isolate Accession No. Description Top named hit Host plant
F0194 3993 B1-2[3](10) AJ542528.1 Uncultured fungus voucher
CSIRO (M) E7391
Fungal endophyte isolate 85 Desmotes incomparabilis (Riley)
Kallunki (Rutaceae)
F0268 314B2-2 EU040233.1 Ochrocladosporium elatum
strain CBS 146.33
Tetrapterys sp.
F0275 34A1(60) EU686869.1 Fungal endophyte 
isolate 1455
Stenocarpella maydis culture-
collection NRRL:13615
Platypodium elegans V. (Fabaceae)
F0305 3993B1(10)(72) AB158315.1 Trametes maxima* Desmotes incomparabilis (Riley)
Kallunki (Rutaceae)
F0307 371B4[11](21) FJ612751.1 Fungal sp. ARIZ L262 Xylariaceae sp. E6923c Desmotes incomparabilis (Riley)
Kallunki (Rutaceae)
F0324 215C1 HM537066.1 Fungal endophyte sp. g93 Nigrospora sp. SGLMf43 Ladenbergia brenesii
F0392 371B2[5](16) AY908991.1 Camarops ustulinoides strain
PR113
Fungal endophyte 
isolate 1947
Desmotes incomparabilis (Riley)
Kallunki (Rutaceae)
F0404 3994 B2-3[7](21) EU687033.1 Fungal endophyte
isolate 2157
Cercophora sparsa
voucher JF00229
Desmotes incomparabilis (Riley)
Kallunki (Rutaceae)
F0407 3993 B1-2[1](8) EU687033.1 Fungal endophyte
isolate 2157
Cercophora sparsa
voucher JF00229
Desmotes incomparabilis
F0755 349B1 EF565744.1 Edenia gomezpompae
strain C1c 18S
Petrea volubilis L (Verbenaceae)
F0819 EU687098.1 Fungal endophyte isolate 343 Xylariales cf. JP14-3 Poulsenia armata
F1220 420B4-14 FJ799950.1 Xylaria sp. SAB-2009a 
strain Q1343
unidentified (Poaceae)
F1491 157B2(368) AJ558114.1 Nectria mauritiicola Macuna mutisiana (Kunth) DC.
(Fabaceae)
F1534 65B6(30) DQ480346.1 Penicillium paxilli
isolate A71
Philodendron tripartitum (Jacq.)
Schott (Araceae)
F1544 20C4(68) HQ631021.1 Aspergillus sp. TMS-2011
voucher BGd1p19-4
Unidentified
F1559 EU563525.1 Fungal sp. 144C2i Diaporthe eres
isolate MB0839_1 
Unidentified
F1566 20B3(4) FJ799940.1 Diaporthe sp. SAB-2009a
strain Q1160
Unidentified (Cyperaceae)
F1642 68B1(24) FJ612855.1 Fungal sp. ARIZ L525CLA Xylaria sp. F-069,049 Siparuna pauciflora (Beurl.) A. DC.
(Siparunaceae)
F1644 15C1(267) EF565744.1 Edenia gomezpompae
strain C1c
Drymonia serrulata
F1647 164B2(1) EU563572.1 Fungal sp. 192c2g Diaporthe phaseolorum
strain AK25A
Castilla elastica Sessé & Cerv.
(Moraceae)
F1664 86A2(86) FJ434202.1 Hypocrea sp. LY 30.1 Cecropia longipes Pitt. (Cecropiaceae)
F1717 125B1(107) EU490050.1 Uncultured ascomycete
clone C31_C08
Shiraia bambusicola Sloanea zuliaensis Pittier
(Elaeocarpaceae)
F1815 59A1(219) EU686869.1 Fungal endophyte 
isolate 1455
Phomopsis sp. WF167W Vitis tiliifolia Humb. & Bonpl.
(Vitaceae)
F2140 433B1-4 EU167598.2 Mycosphaerella stromatosa** Psychotria sp. (Rubiaceae)
*Phylogenetic analysis reveals placement in Pycnoporus [27]. **Phylogenetic analysis confirms placement in Mycosphaerella [8].
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anticancer activities of the fungal extracts are summarized in
Table 2.
Anti-leishmanial activity. Of the 25 fungi tested,
seven (Edenia sp. strain F0755, Penicillium sp. strain F1534,
Diaporthe sp. strain F1566, unidentified sp. strain F0194,
Nectria sp. strain F1491, Mycosphaerella sp. strain F2140
and Hypocrea sp. strain F1644) showed marked anti-leish-
manial activity, with at least one extract of each of these
fungi showing >90% inhibition. Other strains, such as
Stenocarpella sp. strain F0275, Xylaria sp. strain F1220,
Aspergillus sp. strain F1544, Diaporthe sp. strain F1647, and
Xylariaceae sp. strain F0307, showed moderate antileishma-
nial activity (at least one extract of each fungus showed
>60% inhibition). These results suggest that new antileish-
manial drugs can be obtained from endophytic fungi. 
Thus far, only a few natural fungal-derived compounds
with antileishmanial activity have been described. IB-01212,
an antitumoral cyclodepsipeptide isolated from the marine
fungus Clonostachys sp., was shown to have leishmanicidal
activity on promastigote and amastigote forms of the parasite
at low micromolar concentrations [20]. Chaetoxanthone C,
isolated from the marine fungus Chaetomium sp., was report-
ed to exhibit moderate activity against T. cruzi, with an IC50
value of 1.5 μg/ml [26]. 
Antimalarial activity. Only three strains (Stenocar-
pella sp. strain F0275, Nectria sp. strain F1491, and Myco-
sphaerella sp. strain F2140) had antimalarial activity (>90%
inhibition of the parasite). Another five isolates (Penicillium
sp. strain F1534, Phomopsis sp. strain F1815, Trametes sp.
strain F0305, Xylariaceae sp. strain F0307, and Ochro-
cladosporium sp. strain F0268) showed moderate inhibition
(Table 1).
Antimalarial activity has been demonstrated in com-
pounds isolated previously from endophytic fungi.
Monocerin and 11-hydroxymonocerin, natural products iso-
lated from the endophytic fungus Exserohilum rostratum, are
active against P. falciparum (K1, multidrug-resistant strain)
with IC50 values of 0.68 and 7.70 μM, respectively [28]. The
benzoquinone metabolites 2-chloro-5-methoxy-3-methylcy-
clohexa-2,5-diene-1,4-dione and xylariaquinone A, obtained
from Xylaria sp., are active in vitro against P. falciparum K1
strain, with IC50 values of 1.84 and 6.68 μM, respectively
[30]. Phomoxanthones A and B, isolated from Phomopsis sp.
BCC 1323, show significant activity against Plasmodium fal-
ciparum (K1, multi drug-resistant strain) [16]. 
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Table 2. The growth-inhibitory effect (% IG) of total extracts from active
endophytic fungi against tropical parasites and MCF-7 cancer cell line
Isolate CM L. donovani P. falciparum T. cruzi MCF-7
F0275 A 83.0 I I I
B 71.1 76.2 92.7 I
D 72.1 I I I
F0755 A 98.5 I I I
B 98.1 I I I
C 96.8 I I I
D 97.4 I I I
F1220 D 65.3 I I I
F1534 B I 98.0 I I
C 92.9 I 76.5 I
F1544 A 70.1 I I I
B 72.9 I I I
C 77.2 I I I
F1566 C 98.3 I 86.7 I
D 98.1 I I I
F1642 C I I I 74.0
F1647 C 80.0 I I I
D 71.0 I I I
F0194 B 93.4 I I I
F1491 B 76.2 I 81.1 79.9
C 97.2 I I I
F1815 C I 75.8 I I
F0305 A I 70.2 I I
F0307 A I 70.6 I I
B 66.2 68.3 I 93.8
C I I I 90.4
F2140 A 94.4 I 91.9 86.5
B 93.6 I 94.3 I
C 96.7 100.0 95.9 87.3
D 96.8 88.7 92.8 80.3
F1644 B 95.4 I I I
C 96.0 I I I
F0268 A I 77.2 80.4 I
B I I I 78.7
CM, culture medium used for fungal growth. A, malt extract. B, potato dex-
trose broth. C, Czapek Dox. D, V8 juice. I, inactive.
100 INT. MICROBIOL. Vol. 14, 2011 MARTÍNEZ-LUIS  ET AL.
Anti-trypanosomiasis activity. Most of the extracts
in this study failed to significantly inhibit Trypanosoma
cruzi. Among the 25 isolates, high activity against this para-
site was determined only in Mycosphaerella sp. strain F2140.
However, moderate inhibition was obtained with extracts
from Stenocarpella sp. strain F0275, Penicillium sp. strain
F1534, Diaporthe sp. strain F1566, Nectria sp. strain F1491,
and Ochrocladosporium sp. strain F0268 (Table 1).
As with leishmaniasis, only a few fungally derived com-
pounds able to inhibit trypanosomiasis have been described.
Ascofuranone, isolated from the fungus Ascochyta viciae,
has shown good therapeutic effects for African trypanosomi-
asis in mice [25]. 
Anticancer activity in vitro. In the anticancer assay,
the pattern was similar to that observed in the bioassay
against T. cruzi. In fact, good anticancer activity was con-
firmed in only two strains (Xylariaceae sp. strain F0307 and
Mycosphaerella sp. strain F2140). Of the strains tested, four
(Diaporthe sp. strain F1566, Xylaria sp. strain F1642,
Nectria sp. strain F1491, and Ochrocladosporium sp. strain
F0268) produced metabolites that moderately (60–80%)
inhibited the cancer cell line MCF-7 (Table 1).
Endophytic microorganisms are major reservoirs of anti-
cancer secondary metabolites. For example, two new nors-
esquiterpene peroxides (talaperoxides B and D), isolated
from the mangrove endophytic fungus Talaromyces flavus
are cytotoxic against five human cancer cell lines (MCF-7,
MDA-MB-435, HepG2, HeLa, and PC-3), with IC50 values
ranging from 0.70 to 2.78 μg/mL [19]. The cyclic depsipep-
tide 1962A, isolated from an unknown mangrove endophytic
fungus, is weakly active against human breast cancer MCF-7
cells [13]. Moderate activity against four cancer cell lines,
NCI-H460 (non-small cell lung cancer), MCF-7 (breast can-
cer), SF-268 (CNS glioma), and MIA Pa Ca-2 (pancreatic car-
cinoma), and normal human fibroblast cells (WI-38) [3], was
determined for globosumones A and B, isolated from
Chaetomium globosum, an endophyte of Ephedra fasciculata.
Effect of culture media on parasitic activity.
Endophytic fungi are a potential source of a variety of new
metabolites, which can be produced by a single strain follow-
ing systematic modification of its cultivation parameters, a
phenomenon known as the OSMAC approach (one strain of
many compounds) [12]. This approach reflects the fact that
very small changes in the growing conditions of a microor-
ganism can completely alter its metabolic profile.
Consequently, the same strain can express various activities
depending on the culture medium and/or the specific culture
environment [12]. Based on these observations, the fungi
examined in this study were grown on four media containing
different amounts of nutrients and the effects on bioactivity
were determined. 
Indeed, each medium was found to have a particular
effect on biological activity. Extracts with greater activity
were consistently obtained when the fungi were grown on
nutrient-poor Czapek Dox medium. Nutrient limitations are a
typical form of stress in fungi, as in other organisms, and the
transduction of these stress signals induces a protective
response to allow survival in a hostile environment. Of the
three nutrient-rich media used in this study, potato dextrose
broth yielded much more active extracts than obtained with
the other two media, most likely due to differences in the
amounts of carbon and nitrogen sources [9,31]. 
Isolation of bioactive compounds from Edenia
sp. strain F0755 and Mycosphaerella sp. nov.
strain F2140. The main goal of our research group is to
find alternatives for the treatment of parasitic diseases, which
the WHO still consideres as neglected diseases. Parasitic dis-
eases and cancer are widespread, affecting populations in
several regions of the world [10,14]. The drugs used to treat
these diseases are highly toxic, such as the arsenic-based
compounds prescribed for the treatment of Leishmania [10].
In fact, in some cases patients die from the effects of the drug
itself, rather than directly from the disease. 
Endophytic fungi are a promising source of novel thera-
peutic agents and are of particular interest in the treatment of
leishmaniasis and malaria. Many studies have shown that
they are a promising source of new, biologically active com-
pounds, including secondary metabolites of biological utility.
In light of these observations, we chemically analyzed
Edenia sp. strain F0755 and Mycosphaerella sp. nov. strain
F2140; those studies are summarized below.
Edenia sp. strain F0755. Figure 1 shows the active
compounds isolated from this fungus. The six compounds
were identified as non-symmetrical dimers of 1,8-dihydroxy-
naphthalene. Compounds 2, 3, and 4 are new natural prod-
ucts but all six compounds significantly inhibited the growth
of Leishmania donovani in the amastigote form, with IC50
values of 3.93, 1.34, 0.62, 11.6, 8.40, and 0.12 μM, respec-
tively. However, at concentrations of 10 μg/ml none of the
compounds was active against Plasmodium falciparum and
Trypanosoma cruzi, which suggested the selective activity of
all of them against Leishmania. In addition, compounds 1–6
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showed weak cytotoxicity to Vero cells (IC50 of 162, 174,
152, 140, 9, and 150 μM, respectively). The therapeutic win-
dow of these compounds was determined to be highly signif-
icant, with, respectively, 41, 130, 245, 18, 75 and 12 times
greater anti-leishmanial activity than cytotoxicity [21,22].
Mycosphaerella sp. nov. strain F2140. Our chemi-
cal investigations of a new endophytic fungus, Mycosphaerel-
la sp. nov. strain F2140, associated with the foliage of the plant
Psychotria horizontalis (Rubiaceae), resulted in the isolation
of cercosporin (Fig. 1, compound 7), an antiparasitic com-
pound, and of four other compounds, as major components.
The isolated compounds were tested in vitro to determine their
antiparasitic activity against the causal agents of malaria
(Plasmodium falciparum), leishmaniasis (Leishmania dono-
vani), and Chagas disease (Trypanosoma cruzi), but only cer-
cosporin showed potent antiparasitic activity. To evaluate the
influence of the hydroxyl groups of cercosporin on its anti-par-
asitic activity, the acetylated derivative of this compound was
prepared. Cercosporin and its acetylated derivative were highly
potent against L. donovani (IC50 0.46 and 0.64 μM, respective-
ly), T. cruzi (IC50 1.08 and 0.78 μM, respectively), and P. falci-
parum (IC50 1.03 and 2.99 μM, respectively). Both compounds
also showed potent cytotoxic activity against the human breast
cancer cell line MCF-7 (IC50 4.68 and 3.56 μM, respectively).
This result suggests that the high antiparasitic activity of cer-
cosporin is due to its high cytotoxicity [24].
In conclusion, endophytic fungi may be a promising
source of bioactive natural products, since 64% of the strains
analyzed in this study exhibited antiparasitic activity. Nine of
these strains (Edenia sp. strain F0755, Xylaria sp. strain F1220,
Aspergillus sp. strain F1544, Diaporthe sp. strain F1647,
unidentified sp. strain F0194, Edenia sp. strain F1644, Pho-
mopsis sp. strain F1815, Trametes sp. strain F0305 and Xylaria
sp. strain F1642) showed promising selective activity. 
In previous studies of chemicals extracted from selected
endophytic fungi, we obtained several compounds with
potent anti-parasitic activity [16,20,25,26,28,30], which jus-
tifies the screening of endophytic fungi as a source of lead-
ing compounds for the development of antiparasitic drugs.
Based on the excellent antiparasitic activity of the endophyt-
ic fungi Edenia sp. strains F0755 and Mycosphaerella sp.
nov. strain F2140 in our preliminary bioassay, these isolates
were subjected to further chemical study and their bioactive
compounds further characterized.
The ongoing development of new antiparasitic agents is
important to overcome the limitations related to the high
toxicity of the drugs currently available for the treatment of
diseases caused by tropical parasites [7]. The use of these
toxic chemotherapeutic compounds, such as sodium sti-
bogluconate and meglumine antimonate, is associated with
numerous, potentially fatal side effects [7]. While endophytic
fungi are an abundant and reliable source of metabolites
with medicinal and agrochemical applications, they have
been only scarcely explored as sources for antiparasitic
agents. As evidenced by our findings, Panamanian plants
might provide a wealth of new antiparasitic and anticancer
compounds.
ANTIPARASITIC ACTIVITY OF ENDOPHYTIC FUNGI
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Fig. 1. Antiparasitic metabolites isolated from Edenia sp. strain F0755 (1-6) and from Mycosphaerella sp. nov. strain F2140 (7). (1) Palmarumycin CP2;
(2) palmarumycin CP17; (3) palmarumycin CP18; (4) palmarumycin CP19; (5) CJ-12,371 and (6) preussomerin EG1, (7) cercosporin.
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